- Kyowa Kirin Provides Update on Application for Marketing Authorisation of Istradefylline in Europe for the Treatment of ‘OFF’ Episodes in People Living with Parkinson’s
- Kyowa Kirin Announces EU Approval for the Self-administration of CRYSVITA® ▼ (burosumab) to Treat X-Linked Hypophosphataemia (XLH)
- Kyowa Kirin: New Data Analysis Shows Link between Blood Involvement and Response to Treatment in Cutaneous T-cell Lymphoma (CTCL) Patients
- Kyowa Kirin Receives Positive CHMP Opinion for the Self-administration of CRYSVITA® ▼ (burosumab) to Treat X-Linked Hypophosphataemia (XLH), a Rare Metabolic Bone Disorder
Kyowa Kirin Co Ltd (4151:TYO) closed at 3,425.00, -16.05% below its 52-week high of 4,080.00, set on Jul 13, 2021.
2,559.00Nov 02 20204,080.00Jul 13 2021
Markit short selling activity
|Market cap||1.87tn JPY|
|EPS (TTM)||82.42 |
|Annual div (ADY)||45.00 |
|Annual div yield (ADY)||1.30%|
|Div ex-date||Jun 29 2021|
|Div pay-date||Sep 01 2021|
|Next div ex-date||Dec 29 2021|
|Next div pay-date||--|
Data delayed at least 20 minutes, as of Aug 05 2021 07:00 BST.